To avoid overt anti-tumor responses, tumor cells commonly either degrade self-nucleic acids or deactivate crucial sensing systems, such as cGAS/STING signaling, thereby minimizing the production of type I IFNs and associated anti-tumor immune responses. This evidence concerns the gene STING1 and neoplasm.